Download eBook for Free

Full Document

FormatFile SizeNotes
PDF file 3.8 MB

Use Adobe Acrobat Reader version 10 or higher for the best experience.

Annexes

FormatFile SizeNotes
PDF file 0.6 MB

Use Adobe Acrobat Reader version 10 or higher for the best experience.

Executive Summary

FormatFile SizeNotes
PDF file 1.7 MB

Use Adobe Acrobat Reader version 10 or higher for the best experience.

La charge sociétale et économique de l'insomnie chez l'adulte: Une étude internationale (Résumé analytique)

French Executive Summary

FormatFile SizeNotes
PDF file 1.7 MB

Use Adobe Acrobat Reader version 10 or higher for the best experience.

Die gesellschaftlichen und wirtschaftlichen Belastungen durch Schlaflosigkeit bei Erwachsenen: Eine internationale Studie (Zusammenfassung)

German Executive Summary

FormatFile SizeNotes
PDF file 1.7 MB

Use Adobe Acrobat Reader version 10 or higher for the best experience.

L'onere sociale ed economico dell'insonnia negli adulti: Uno studio internazionale (Sintesi)

Italian Executive Summary

FormatFile SizeNotes
PDF file 1.7 MB

Use Adobe Acrobat Reader version 10 or higher for the best experience.

Carga social y económica del insomnio en adultos: Un estudio internacional (Resumen)

Spanish Executive Summary

FormatFile SizeNotes
PDF file 1.7 MB

Use Adobe Acrobat Reader version 10 or higher for the best experience.

Samhällsbelastning och ekonomisk belastning av sömnlöshet hos vuxna: En internationell studie (Sammanfattning)

Swedish Executive Summary

FormatFile SizeNotes
PDF file 1.7 MB

Use Adobe Acrobat Reader version 10 or higher for the best experience.

In this study, we sought to understand the societal and economic burden of insomnia in high-income, Organisation for Economic Co-operation and Development countries within Northern, Southern and Western Europe, as well as North America and Australia. The focus of the study was on adult populations with chronic insomnia, defined as difficulty falling or staying asleep or non-restorative sleep experienced at least 3 times per week for at least 3 months, with daytime impairment. Methods included a review of the published literature, secondary database analyses and economic modelling. We identified information from the literature on insomnia among 16 countries across the regions of interest, with an overall estimated prevalence of chronic insomnia of 8%, representing approximately 41.6 million working-age adults. We found that insomnia is associated with poorer self-rated life satisfaction and estimated that individuals with insomnia would be willing to trade approximately 14% of their annual per capita household income to avoid its negative consequences. At the national level this translates to between $1.5 and $127.1 billion, annually, attributable to chronic insomnia (in 2019 United States Dollars [USD]). Chronic insomnia is also associated with an average loss in workplace productivity of 45-54 days, resulting in estimated annual losses in national gross-domestic product ranging from 0.64% to 1.31%, or approximately $1.8 to $207.5 billion (2019 USD). Given the substantial societal and economic effects of insomnia, strategies are needed to better mitigate its burden to positively impact the health, well-being and productivity of individuals and society, as a whole.

Key Findings

  • Approximately 8% of adults suffer from chronic insomnia.
  • Individuals with insomnia are estimated to be willing to trade approximately 14% of their annual per capita household income to avoid its negative consequences.
  • Chronic insomnia is associated with an average loss of 45-54 days in workplace productivity, resulting in estimated annual losses in national gross-domestic product ranging from 0.64% to 1.31%, or approximately $1.8 to $207.5 billion.

Research conducted by

This report was funded by Idorsia Pharmaceuticals Ltd. Switzerland and conducted by RAND Europe.

This report is part of the RAND research report series. RAND reports present research findings and objective analysis that address the challenges facing the public and private sectors. All RAND reports undergo rigorous peer review to ensure high standards for research quality and objectivity.

This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.

RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.